智通财经APP讯,TATA健康(01255)发布公告,截至本公告日期,公司核数师正就2023年年度业绩的审核进行相关审核程序。由于2023年年度业绩及2024年中期业绩尚待刊发,预计2024年年度业绩及2024年年度报告将不会根据上市规则的规定分别于2025年3月31日前刊发及于2025年4月30日前寄发予股东。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.